The fundamental shift in the make-up of the Canadian dental practice detected in previous reports is continuing, according to results from the DIAC (Dental Industry Association of Canada) Twenty-Second Annual Future of Dentistry Survey. All of the following points may reflect on the impact of the current economic situation on the dental practice in Canada:
• Trend towards increasing numbers of dentists in the practice continues, with 11% of practices with five or more dentists. This was 3.4% in 2016 and an average of 6.3% the last 14 years.
• Growing percentage of respondents describing their location as Urban (now 62% as compared to 56% last year and 51% in 2016) (average of 53% over past ten years). Drop off is in Suburban locations (falling to 22% from 29% last year and an average of 25% over the past 10 years).
• Practices with three or fewer operatories had been generally in steady decline since the survey began, a real drop of 40.2% since 1997.
• 28% of respondents planning to add at least one operatory as opposed to 22% last year.
• The number of hygiene days per practice is increasing overall (with more days being added by those who only had one or two per week previously) - 46% of respondents in 2018 had 5 or more hygiene days per week, as compared to 44% last year and the average of 38.6% the last ten years).
• At the same time, the average number of patients treated per day continues to decline. Unlike last year, where a higher number of specialists responded, the GP/Specialist split on response returned to historical norms in 2018. On an overall basis, dentists treated 11 patients in an average day as compared to the average of 12.5 patients over the last ten years. 89% stated they treated less than 15 patients a day (as opposed to 83% last year and an average of 78.6% over the last four years).
• Reinforcing the 2017 results, dentists continue to move into Multi-practice (Group Practice). While the majority (63%) of respondents stated they were in a solo practice, more than a third (34%) are now in a group practice – and these group practices are getting bigger with 24% having 5 or more operatories (as opposed to 17% in 2017). While the two key advantages attracting those in a multi-practice structure were Associate Support (57%) and Buying Power (20%), “Better hours for patients” had growing support this year with 12% of response. The majority of Group Practice respondents (63%) felt they offered a higher standard of care than a solo practitioner. However, a substantial 23% said they did not. This finding is reinforced by the response to the main drawbacks of a multi-practice (Group practice) structure with 21% citing Consistency of Care (#2 response with Conflict with management style #1 at 29%).
It is little wonder that “Financial/paying bills/overhead” was the top challenge that respondents intended to address in 2018 (as well as the Top Metric for Success in the opinion of 78% of respondents), with “Getting more patients/keep busy” a close second. The majority (60%) of dental practices now offer
patient financing in some fashion, reinforcing results from 2017 (almost one-half (45%) of respondents offered in-house financing while 15% used third party financing) as a way to get those patients.
Financial concerns also appear to have impacted on dentists Practice Management CE activities. The top focus is on building “the Numbers.” The highest rated Practice Management topics for 2018 involve building the business of the practice (ranked in order from highest: Leadership Team Development; Revenue Enhancement/Expense Management; Fraud Protection; and Communication/Case Presentation).
For the first time, Social Media was mentioned by over 50% of respondents as one of the most popular Practice-Building Tools utilized, still second to “Asking for referrals” but trending rapidly upward from 13% in 2012. This movement to on-line promotion mirrors where dental patients are telling practitioners they are getting information on dental treatment options. According to the survey, Internet achieved another all-time high rating and was ranked as the top patient source for the third straight year. This was followed by the more traditional sources of Family members, friends, etc. and Dentist/Dental Team presentations.
A total of 414 practicing Canadian dentists responded to this year’s survey with a good proportional distribution across all regions of the country. Based on this response rate, overall 2018 survey results have an accuracy of +/- 4.7% 19 times out of 20.
BIOLASE, Inc., the global leader in dental lasers, and its employees recently launched a dental laser awareness campaign where BIOLASE employees volunteer to visit local dentists in Los Angeles and Orange County to increase awareness and education around the many benefits of dental lasers.
Since this initiative began three months ago, nearly 650 dentist offices have been visited by more than 40 BIOLASE employee volunteers. The initiative has successfully engaged local community members and practitioners in conversations about how dental lasers can improve outcomes for patients with less-invasive procedures, faster recovery times and less pain and anxiety.
"Our local community, our first 'Model Market,' has always been a priority for us, and we have been overwhelmed by the positive response – both from local dentists and our dedicated team," said John Beaver, Executive Vice President and CFO of BIOLASE. "The activity has been a great way for us to connect with our community in the most direct way, witnessing firsthand the challenges dentists in our area are facing. Initiatives like this allow us to get closer to our customers to ensure we're able to better provide products and services that dentists need to be successful.
"There are multiple benefits on both sides of the chair with the use of dental lasers. They reduce pain and the need for shots, while also improving patient safety by limiting the chance of infection and cross-contamination. Dental lasers can improve patient retention and satisfaction with less time in the chair and faster recovery periods.
This announcement comes on the heels of BIOLASE's recent release of its 2018 Second Quarter results, which showed a nearly 200 percent increase in all-tissue laser sales when compared to the second quarter of 2017 in the Los Angelesand Orange County markets.
About BIOLASE, Inc.
BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment, including three-dimensional CAD/CAM intra-oral scanners and digital dentistry software. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 244 patented and 74 patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold over 37,600 laser systems to date in over 90 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer markets.
Dental disease is preventable and yet, millions of low-income children go without dental care and routine exams each year. In an effort to improve access to care and preventative treatment, 3M Oral Care recently donated over $280,000 in dental products to America’s ToothFairy.
The donation, which consisted of hygiene products, dental equipment, crowns, adhesives and cements were distributed to 21 members of the America’s ToothFairy Dental Resource Program, a national network of nonprofit clinics providing essential oral health care to underserved children and families in their communities. Emphasizing the need for preventative care, more than half of the product donated was 3M™ Vanish™ Varnish and Fast Release Varnish.
“3M strives to assure that children in our communities have access to the care they need and are prepared for life-long success,” said Sebastian Arana, President and General Manager of 3M Oral Care. “It is our hope that these donations will help nonprofit dental clinics provide critical treatment and prevent tooth decay among underserved children.”
“Children who are living in pain from tooth decay lose sleep and miss school,” said Jill Malmgren, Executive Director of America’s ToothFairy. “This generous donation from 3M not only helps our network of clinics treat more children, it demonstrates our shared commitment to prevent the needless suffering from tooth decay in the first place. We are incredibly grateful for 3M’s continued support to improve the oral health of our nation’s youth.”
About 3M Oral Care
3M Oral Care promotes lifelong oral wellness through inventive solutions that help oral care professionals achieve greater clinical, professional and personal success around the world.
About America’s ToothFairy
As a resource provider, America’s ToothFairy increases access to oral health care by supporting nonprofit clinics and community partners delivering education, prevention, and treatment services for underserved children. Since its inception in 2006, America’s ToothFairy has distributed more than $18 million in donated products, educational materials, and financial grants to improve oral health outcomes for children and youth in need. For more information, visit www.AmericasToothFairy.org.
Pulpdent Corporation, a Boston-area dental research and manufacturing company, is working in collaboration with Virtudent, the first commercial teledentistry practice in the United States, to increase access to dental care for low-income children in New Hampshire. Pulpdent has donated 800 applications of Embrace Varnish for Virtudent's program at the Boys and Girls Clubs of NH.
According to the CDC, over 15% of children and adolescents aged 2-17 did not see a dentist in 2015. As a result, thousands of children are rushed to the emergency room every year for preventable dental problems.
Virtudent's research suggests that low-income youth lack access to dental care due to the uneven distribution of dentists in the United States and the relatively small number of dentists who accept Medicaid. The teledentistry practice, which specializes in on-site dental visits for participating companies, is bringing its innovative care model to the Boys and Girls Clubs of New Hampshire. Virtudent currently offers on-site dental care and teledentistry services to 4,200 children at 8 Boys and Girls Clubs locations throughout the Granite State.
The majority (88%) of Virtudent's on-site dental appointments at the Boys and Girls Clubs of New Hampshire include a Fluoride Varnish treatment. Pulpdent has donated 800 applications of Embrace Fluoride Varnish to Virtudent's program for the Boys and Girls Clubs of NH. Embrace Varnish releases fluoride, calcium and phosphate (the basic building blocks of teeth). These essential minerals help strengthen teeth.
About PULPDENT® Corporation
PULPDENT® Corporation is a family-owned dental research, manufacturing company and leader in bioactive dental materials. ACTIVA BioACTIVE™, developed by PULPDENT, is the first esthetic bioactive restorative material. ACTIVA behaves much like natural teeth and stimulates the formation of apatite (the building blocks of teeth), chemically bonds to teeth and helps protect against decay. For over 70 years, Pulpdent has been committed to product innovation, clinical education and patient-centered care in the fields of restoratives, oral hygiene, endodontics, temporization, periodontics, orthodontics, and general dentistry. To stay updated on bioactivity and learn about the Heroic Dentistry Series, which demonstrates ACTIVA's unprecedented capabilities, visit the Pulpdent blog.
The California Dental Association Foundation is recruiting volunteers for its CDA Cares dental event October 26-27 at the Modesto Centre Plaza. To help provide oral health care services at no charge to the large number of expected patients, the CDA Foundation needs volunteer dentists, including oral surgeons, as well as dental hygienists, assistants, dental lab technicians, physicians, nurses, and pharmacists.
Additionally, community volunteers are needed to help escort patients, translate/interpret, dispense medication, set up and tear down the clinic, register patients and volunteers, conduct exit interviews, enter data, and provide oral health education.
The main goal of the clinic is to relieve pain and eliminate infection by providing cleanings, fillings, extractions, and oral health education to about 1,950 people during the two-day event.
To date, the CDA Foundation and CDA have hosted 13 clinics that provided $20.75 million in dental care to more than 25,000 people thanks to the generosity of volunteers and support from the community.
Volunteers are needed in shifts during the following times:
•Thursday, October 25: Clinic setup from 9 am to 6 pm (no patients)
•Friday, October 26: Dental clinic from 5 am to 7 pm
•Saturday, October 27: Dental clinic from 5 am to 9 pm (including clinic breakdown)
Volunteers can sign up for one six-hour shift or multiple shifts per day. Help make CDA Cares Modesto a success! To learn how you can get involved and to register, go to cdafoundation.org/modesto.
PREAT Corporation has announced the addition of Razi Settodegan to the PREAT Team. With over 15 years of experience in the dental industry, Razi has joined PREAT as Director of Customer Success. Her experience as a dental technician and dental assistant will be a wonderful contribution to the PREAT Customer Success Team.
“Razi has the energy and passion for supporting dental laboratories. We are excited to have Razi join the PREAT family and spearhead our continued growth,” PREAT President Chris Bormes said.
Quantum Dental Technologies presented findings of a study at the 96th General Session of the International Association for Dental Research (IADR) in London England. This study found that The Canary System® can detect caries under the intact margins of glass ionomer and compomer restorations more accurately than Spectra, DIAGNOdent and visual examination.
Finding caries beneath intact restoration margins is a challenging clinical problem. Glass Ionomer and Compomers are radiopaque and reflect light from their respective surfaces. The study found that visual examination could not detect caries. The glow or fluorescence from the restorations prevented Spectra from detecting any marginal caries. DIAGNOdent was unable to consistently differentiate sound from carious tissue at various distances from the restoration margins. It was able to detect between 20% ‐ 70% of the lesions beneath the restorations depending upon the distance from the margin. The Canary System was able to detect 91% ‐ 100% of the lesions around the restoration margins. This study demonstrated that The Canary system is a valuable diagnostic tool for detecting caries that develop around and beneath the margins of glass ionomer and compomer restorations.
The findings in this study mirror the findings in studies on detection of caries around amalgam, composite, orthodontic brackets and ceramic crowns. In each of these clinical situations, The Canary System was able to detect over 90% of the lesions beneath these various restorative materials.
“The Canary System provides dentists with the ability to detect and monitor tooth decay beneath the edges of fillings, crowns and bridges; one of the most common clinical conditions that would lead to the failure of these restorations. X‐Rays can only aid clinicians to diagnose decay on the sides or interproximal areas of teeth. When a glass ionomer or compomer restorations are placed, x‐rays can only detect tooth decay in certain limited areas and not along the visible margins”, said Dr. Stephen Abrams, co‐founder of Quantum Dental Technologies. “Compomers and Glass Ionomer may reduce the incidence of marginal breakdown but caries can still develop. Early detection of tooth decay, before it is seen on an x‐ray or detected with visual inspection means that dentists can treat problems before the decay has destroyed large amounts of vital tooth structure.”
The Canary System, with its unique crystal structure diagnostics, can, quantify, image, monitor and record changes in the structure of enamel, dentin and cementum. It can detect caries beneath opaque sealants, around the margins of restorations, around orthodontic brackets and beneath interproximal, occlusal and smooth surfaces.
The Canary Cloud enables dentists to view and analyze this data and track Canary usage in their office. Visit www.thecanarysystem.com or email email@example.com to request additional information.
Bassi Logic™ is a continuous rotary single-file shaping system, one that provides a quantum leap in minimally invasive functionality. The Bassi Logic™ system features files for glidepath preparation and for shaping to treat any canal anatomy.
KaVo Kerr, an organization comprised of two global leaders in dentistry, is pleased to expand its growing portfolio of imaging solutions with the new KaVo NOMAD Pro 2 which allows dental professionals to gain all the reliability and efficiency advantages that every busy dental office needs and appreciates. This robust and convenient system provides a powerful freedom in workflow that is unattainable with wall-mount units. From its safety and portability to its ease of use and innovative features, the KaVo NOMAD Pro 2 is designed with the practice, the clinician, and the patient in mind.
Exemplifying a commitment to safety, the KaVo NOMAD Pro 2 has a unique, lead-infused acrylic shield that protects the operator from scatter radiation while an internal proprietary housing encases the X-ray tube to block radiation leakage. When the KaVo NOMAD Pro 2 is used as directed, these shields create a “safe zone” for the operator throughout the acquisition process.
Dentists can depend on KaVo NOMAD Pro 2 to help produce sharp, clear radiographic images. The system utilizes the latest in X-ray technology— a 0.4 mm focal spot plus a 60kV DC X-ray generator that consistently delivers exacting, repeatable exposures.
Portable and easy to use, the KaVo NOMAD Pro 2 moves freely between operatories and lets clinicians remain chairside when it really counts— creating a more positive radiographic experience for all involved. With KaVo NOMAD Pro 2, there’s an immediate cost savings over multiple operatories that would need wall-mount units. Plus, the KaVo NOMAD Pro 2 is ready for use right out of the box.
The NOMAD Pro 2 now has innovative features such as industry-leading battery technology, an intuitive user interface, and inventive ergonomic design. Incorporating 30% more capacity and longer life than in previous models, the KaVo NOMAD Pro 2 utilizes premier battery technology that provides consistently reliable, long-lasting battery longevity. Clinicians can easily adhere to ALARA and select the right dose for a patient’s particular need by choosing from a variety of easy-to-understand, graphic settings in the redesigned touchpad interface.
“Ergonomics was foremost in the redesign of the KaVo NOMAD Pro 2,” states Brett Bartles, Business Unit Manager, KaVo Kerr. “Based on customer feedback and a review of popular power tools’ design, we were able to create a more secure grip so that the unit overall is much more stable and balanced. This design along with the system’s other highly useful features makes it a real win for any dental practice.”
BIOLASE, Inc., the global leader in dental lasers announced today that it has named Todd A. Norbe, a veteran dental industry executive and a member of the Company's Board of Directors, as President and Chief Executive Officer. BIOLASE also announced that Senior Vice President and Chief Financial Officer John R. Beaver, who has been serving as the Company's Interim Chief Executive Officer, has been promoted to Executive Vice President and Chief Financial Officer.
Mr. Beaver will host today's previously scheduled 2018 second quarter earnings conference call at 4:30 p.m. Eastern Time.
"We are very excited and fortunate to have Todd step in as CEO and believe his willingness to do that, given his vantage point as a board member, demonstrates his bullishness on the future of lasers in dentistry and BIOLASE," said Jonathan T. Lord, M.D., Chairman of the Board. "In the short time that he has been on the BIOLASE Board, he has been a key contributor to the vision and strategy of the Company. Todd is a true leader with excellent management skills and an exceptional record of accomplishment in the global dental market."
Mr. Norbe said, "I look forward to working with the BIOLASE team to advance dentistry that will benefit both the patient and our valued customer, the dentist."
Dr. Lord added, "We are confident that Todd and John, along with our newly-constituted Board of Directors, represent a very strong and experienced leadership team. This group has proven leadership in the dental industry and in driving the adoption of innovation in clinical practice.
"Minimally invasive laser dentistry is the future of the dental industry, especially in growing areas like pediatric care and implant periodontitis. Our team is focused on expanding the adoption of our all-tissue lasers throughout the dental industry.
"Dr. Lord added that the Board of Directors thanked Mr. Beaver and all of the employees for their performance during the four months he served as interim CEO.
"John's effort this quarter was fantastic, and it shows in the results, particularly in the traction we are gaining in our Southern California-focused sales, marketing and training initiative," Lord said. "We are seeing significant increases in both adoption and utilization of all-tissue lasers. Building revenue through the sale of more lasers and recurrent revenue through consumables, is our goal."
Mr. Norbe, 51, who was named to the BIOLASE board in June 2018, is a senior executive with broad experience in the global dental industry. Most recently he was the President, North America of KaVo Kerr, a subsidiary of the Danaher Corporation. KaVo Kerr delivers dental instruments, imaging solutions, dental treatment units and premier consumables worldwide. He served as Vice President and General Manager of Metrex Medical – Sybron Dental Specialties, continuing in that role after it was acquired by Danaher in 2006.
Mr. Norbe has an MBA in Management from Fairleigh Dickinson University, and a BS in Marketing from Bloomsburg University. He has also served on the Board of the Dental Trade Association Foundation and the National Children's Oral Health Foundation.
Mr. Beaver, 57, joined BIOLASE in October 2017 and brought proven leadership and technical experience in finance and business management in both public and private companies.
Prior to joining BIOLASE, Mr. Beaver served as the Chief Financial Officer of San Jose, CA-based Silicor Materials, Inc., a global leader in the production of solar silicon, from 2009 to 2013 and from 2015 to 2017. He also served on Silicor's Board of Directors from 2013 to 2015.
Previously, Mr. Beaver was Senior Vice President Finance and Chief Financial Officer at Sterling Chemicals, a mid-sized public commodity chemical manufacturer. Among his other roles at Sterling he also served as its Vice President, Corporate Controller. Mr. Beaver has a Bachelor of Business Administration degree in Accounting from the University of Texas at Austin, and he is a Certified Public Accountant.
About BIOLASE, Inc.
BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 244 patented and 74 patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold approximately 37,600 laser systems to date in over 90 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer markets.
For updates and information on WaterLase® iPlus™ and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, LinkedIn at www.linkedin.com/company/biolase, Instagram at www.instagram.com/waterlase_laserdentistry, and YouTube at www.youtube.com/biolasevideos.
BIOLASE® and WaterLase® are registered trademarks of BIOLASE, Inc.
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements, as that term is defined in the Private Litigation Reform Act of 1995 that involve significant risks and uncertainties, including statements regarding anticipated growth. Forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," "should," and variations of these words or similar expressions. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect BIOLASE's current expectations and speak only as of the date of this release. Actual results may differ materially from BIOLASE's current expectations depending upon a number of factors affecting BIOLASE's business. These factors include, among others, adverse changes in general economic and market conditions, competitive factors including but not limited to pricing pressures and new product introductions, uncertainty of customer acceptance of new product offerings and market changes, risks associated with managing the growth of the business, and those other risks and uncertainties that are described, from time-to-time, in the "Risk Factors" section of BIOLASE's annual and quarterly reports filed with the Securities and Exchange Commission. Except as required by law, BIOLASE does not undertake any responsibility to revise or update any forward-looking statements.